| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Merck & Co., Inc. (MRK) has 26 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. MRK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 456.9K | $52.93M | - | |
| VP | 197.9K | $22.92M | - | |
| Dir | 110.9K | $12.85M | - | |
| Pres | 96.8K | $11.21M | - | |
| CFO | 94.2K | $10.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2015 | Frazier Kenneth C | Chairman, President &CEO | Sale+OE | 18,666 | $54.69 | $1,020,757.68 | -4.1% | |
| Oct 29, 2015 | Ambrose Adele D | Sr.v-p &Chief Comuns Officer | Sale+OE | 37,313 | $55.08 | $2,055,334.37 | -65.5% | |
| Oct 28, 2015 | Wendell Peter C | Director | Sale+OE | 5,000 | $54.85 | $274,237.00 | -83.3% | |
| Jul 31, 2015 | Golestani Clark | EVP &Chief Info Officer | Sale+OE | 31,831 | $59.09 | $1,880,804.60 | -18.4% | |
| May 11, 2015 | Schechter Adam H | EVP &Pres-global Human Health | Sell | 10,634 | $60.44 | $642,767.88 | -100% | |
| May 8, 2015 | Gerberding Julie L. | EVP Strat Comm, Gl Pub Policy | Sale+OE | 38,368 | $60.99 | $2,339,949.22 | -54.5% | |
| May 4, 2015 | Kuhlik Bruce N | Exe V-p &Gen Counsel | Sale+OE | 56,064 | $60.20 | $3,374,794.91 | -27.2% | |
| Apr 29, 2015 | Holston Michael J | EVP, Legal | Sale+OE | 95,624 | $59.84 | $5,722,541.78 | -70.5% | |
| Apr 29, 2015 | Kuhlik Bruce N | Exe V-p &Gen Counsel | Sale+OE | 156,902 | $59.82 | $9,386,645.77 | -29.2% | |
| Feb 18, 2015 | Frazier Kenneth C | Chairman, President &CEO | Sale+OE | 5,164 | $58.67 | $302,958.97 | -1.4% |